13 hasil untuk "Angelo Ferrantelli"
Menampilkan 1–13 · 0,27 detik · RSS
-
Artikel Jurnal
Corrigendum: SGLT2 inhibitor role in cardio-metabolic–renal diseases: a narrative review of recent evidence and their pharmacological, clinical and economic implications
The authors wish to make the following corrections to their article: Manunta M, Bruno GM, Ferrantelli A, Ramirez RF, Nardi F. SGLT2 inhibitor role in cardio-metabolic-renal diseases: a narrative review of recent evidence and their pharmacological, clinical and economic implications. Drugs Context…
-
Artikel Jurnal
SGLT2 inhibitor role in cardio-metabolic-renal diseases: a narrative review of recent evidence and their pharmacological, clinical and economic implications
Cardio-metabolic-renal (CMR) conditions, including type 2 diabetes mellitus, cardiovascular disease and chronic kidney disease, represent some of the most pressing public health challenges of the 21st century. In recent years, sodium–glucose co-transporter 2 (SGLT2) inhibitors (SGLT2is) have…
-
Artikel Jurnal
Does Systematic Preliminar Colour Doppler Study Reduce Kidney Biopsy Complication Incidence?
While ultrasonography is widely performed prior to biopsy, colour Doppler examination is often used only to discover post-biopsy complications. Aim of this paper was to evaluate the usefulness of colour Doppler examination in planning the optimal site of puncture for renal biopsy. Present analysis…
-
Artikel Jurnal Teks lengkap
Acute kidney injury in a patient with metabolic syndrome
Introduction: The metabolic syndrome (MS) encompasses many metabolic abnormalities and the insulin resistance is considered as one of the most significant denominators. The chronic kidney disease (CKD) is an emerging health problem but only few patients would reach the end stage renal disease…
-
Artikel Jurnal
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial
Significance Statement A cyclic regimen of corticosteroid and cyclophosphamide is the first-line therapy for membranous nephropathy. Rituximab is superior to conservative treatment and noninferior to cyclosporine in inducing remission; it also may have a more favorable safety profile compared with…
-
Artikel Jurnal
Missing Opportunity for Nephroprotective Therapy in Patients With Non-Dialysis CKD Under Stable Nephrology Care
Introduction: Awareness of the implementation of guideline-directed nephroprotective therapy is an essential preliminary step to optimize implementation of nephroprotective strategies in nondialysis chronic kidney disease (CKD) (ND-CKD). However, updated information on this issue is lacking in the…